Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Xperi Inc.
13G/A
Amendment 1
XPER · 98423J101
|
5.1% |
8/14/2026
Event 6/30/2026
|
|||
| Clearline Capital LP | 5.1% | ||||
| Clearline Capital LLC | 5.1% | ||||
| Marc Majzner | 5.1% | ||||
|
Xperi Inc.
13G
XPER · 98423J101
|
6.4% |
2/17/2026
Event 12/31/2025
|
|||
| Clearline Capital LP | 6.4% | ||||
| Clearline Capital LLC | 6.4% | ||||
| Marc Majzner | 6.4% | ||||
|
MAGNACHIP SEMICONDUCTOR Corp
13G/A
Amendment 1
MX · 55933J203
|
4.1% |
2/17/2026
Event 12/31/2025
|
|||
| Clearline Capital LP | 4.1% | ||||
| Clearline Capital, LLC | 4.1% | ||||
| Marc Majzner | 4.1% | ||||
|
Heron Therapeutics, Inc. /DE/
13G/A
Amendment 1
HRTX · 427746102
|
6.7% |
2/17/2026
Event 12/31/2025
|
|||
| Clearline Capital LP | 6.7% | ||||
| Clearline Capital LLC | 6.7% | ||||
| Marc Majzner | 6.7% | ||||
|
Heron Therapeutics, Inc. /DE/
13G
HRTX · 427746102
|
5.3% |
11/26/2025
Event 9/30/2025
|
|||
| Clearline Capital LP | 5.3% | ||||
| Clearline Capital LLC | 5.3% | ||||
| Marc Majzner | 5.3% | ||||
|
MAGNACHIP SEMICONDUCTOR Corp
13G
MX · 55933J203
|
5.1% |
2/12/2025
Event 12/31/2024
|
|||
| Clearline Capital LP | 5.1% | ||||
| Clearline Capital, LLC | 5.1% | ||||
| Marc Majzner | 5.1% | ||||
|
TherapeuticsMD, Inc.
13G
TXMD · 88338N206
|
5.5% |
2/12/2025
Event 12/31/2024
|
|||
| Clearline Capital LP | 5.5% | ||||
| Clearline Capital, LLC | 5.5% | ||||
| Marc Majzner | 5.5% | ||||